MapLight Therapeutics, Inc.: CEO Christopher A. Kroeger sold 73,691 shares

What happened

• Christopher A. Kroeger, chief executive officer, sold 73,691 shares on Oct 15, 2026, reported at a weighted average price of $8.08 for total proceeds of $595,423.

Key details

• Transaction date and price: Oct 15, 2026; weighted average price $8.08 (shares sold in multiple transactions at prices ranging from $7.755 to $8.3732).
• Shares owned after the transaction: not specified in the filing provided.
• Footnotes: F1 states the sale was to cover statutory tax withholding tied to RSU vesting and was mandated by the issuer ("sell to cover"); F2 explains the reported price is a weighted average and offers to provide per-trade detail on request; F3 notes the shares are held by the C&M Kroeger Nominee Trust, of which the reporting person is co-trustee with his spouse and has voting and dispositive power.
• Filing timing: transaction reported on a Form 4 filed Oct 16, 2026, covering the Oct 15, 2026 transaction.

Why it may matter

• The filing states this was a sell-to-cover transaction related to tax withholding on vested restricted stock units, not described as a discretionary sale.
• This filing does not show why the insider traded or why the company acted.